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Background: To investigate the antifungal activity of propolis, triple antibiotic paste (TAP), 2% chlorhexidine gel
and calcium hydroxide with propylene glycol on Candida albicans-infected root canal dentinal tubules at two
different depths (200 μm and 400 μm) and two time intervals (day 1 and 7).
Methods: A total of 90 extracted human teeth were sectioned below the cementoenamel junction and the apical
part of the root to obtain 6 mm of the middle third of the root. The root canal was enlarged to an internal
diameter of 0.9 mm using Pesso Reamer size no. 2 (Mani®, UT, Japan), followed by canal irrigation and autoclaved.
The specimens were infected for 21 days with C. albicans. Then, the specimens were divided into five groups prior
to placement of intracanal medicaments. Group 1 (propolis), Group 2 (triple antibiotic paste), Group 3
(2% chlorhexidine Gel), Group 4 (calcium hydroxide with propylene glycol), and Group 5 (sterile saline as negative
control). At the end of 1 and 7 days, dentine shavings were collected at two depths into the dentinal tubules (200 μm
and 400 μm), and the total numbers of colony forming units were calculated for assessing the remaining vital viable
fungal population. The values were analysed statistically using non-paramatric Kruskal-Wallis and Mann–Whitney-U
tests to compare the median reduction of Candida albicans between all intracanal medicaments. Probability values
of P < 0.05 were set as the reference for statistically significant results.
Results: The reduction in number of colony forming units was statistically significant in all groups compared to
the control group (sterile saline), except propolis at day 1 (400 μm depth).
Conclusion: Propolis was less effective than triple antibiotic paste, 2% chlorhexidine gel and calcium hydroxide
with propylene glycol against C. albicans on day 1 at 400 μm deep inside the dentinal tubules, but equally
effective after 7 days at both depths.
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Microorganisms are the major causative agents in the de-
velopment of pulpal and periapical inflammation. It has
been shown that periapical lesions heals at a higher rate in
teeth in the absence of microbial contamination/infection
in the root canal [1]. The primary objective of endodontic
treatment is to eliminate microorganisms from the infected
root canal system. Chemomechanical instrumentation
removes the majority of the microorganisms; however,* Correspondence: abhishek_parolia@imu.edu.my; fabian_davamani@imu.edu.my
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unless otherwise stated.it is difficult to completely eliminate the microorganisms
because of anatomical complexity and the limitation in
accessing the canal system by instruments and irrigants [2].
There has been a growing concern about persistent ap-
ical periodontitis, in which microorganisms are resistant
to routine therapy and the infection may persist despite
treatment [3]. Therefore, the need for intracanal medica-
tion increases especially in those cases where infection is
resistant to the regular treatment and the outcome of end-
odontic therapy is compromised. Years of microbiological
studies on persistent apical periodontitis have shown that
Candida albicans are the most commonly found fungi,
ranging from 7-18% of the infections [4]. C. albicans aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ence of C. albicans in an infected root canal is highly
favorable [5-7].
C. albicans retains several virulence factors which can
contribute to persistent apical periodontitis. The hyphal
formation and thigmotropism property allow C. albicans
to penetrate deep into the dentinal tubules, and also
phenotypic alteration of C. albicans helps to adapt in
ecologically harsh conditions, as in high alkaline envir-
onment [8]. These virulence factors render C. albicans
to be resistant to calcium hydroxide, which is the most
commonly used intracanal medicament [9]. Additionally
in the dentinal tubules the buffer substances can prevent
calcium hydroxide activity by causing the pH to be low-
ered drop [10,11].
Calcium hydroxide has limitation, the base water is
acidic because it is self-regulating and does not raise the
pH, and a variety of agents have been introduced as
inter-appointment medicaments. These intracanal medi-
caments must be able to penetrate deep into the dentinal
tubules in the presence of microbes to ensure the
complete eradication of infection from the entire root
canal system.
Chlorhexidine (CHX) is widely used in endodontics as
an irrigant and intracanal medicaments. CHX has a rea-
sonably wide range of activity against aerobic and anaer-
obic organisms as well as Candida species. CHX acts by
releasing positively charged molecule to allow CHX mol-
ecule to penetrate into the microorganism cell, resulting
in cell death [10]. Chlorhexidine was demonstrated to be
highly efficient against C. albicans when compared to
calcium hydroxide, especially in gel formulations at 2%
concentration [12].
Hoshino et al. introduced the use of triple antibiotic
paste, which is a mixture of ciprofloxacin, metronidazole
and minocycline. Studies have shown that topical appli-
cation of this paste disinfects the dentinal lesions and
recalcifies the softened dentin [13-15]. These antibiotics,
in combination, have been reported to be able to penetrate
through dentinal tubules and eradicate anaerobic, Gram-
positive and Gram-negative microorganisms [16,17].
Propolis, a strongly adhesive resinous compound pro-
duced by Apis mellifera L. bees, demonstrated antimicro-
bial activity and used in treatment of bacterial, fungal and
inflammatory diseases [18]. The major chemical compo-
nent present in propolis are flavonoids, phenolics, and
various aromatic compounds. Flavonoids are well- known
plant compounds that have antioxidant, anti- bacterial, an-
tifungal, antiviral, and anti-inflammatory properties [19,20].
Propolis is well known for its antifungal activities against
C. albicans [21-26]. However, its effect against C. albicans
in the dentinal tubules is scarcely studied.
Therefore, the purpose of this ex vivo study was to evalu-
ate and compare the antifungal effectiveness of propolis,triple antibiotic paste, 2% chlorhexidine gel, and calcium
hydroxide with propylene glycol against C. albicans.
Methods
The investigation protocol was approved by the Research
and Ethics Committee of International Medical University.
The method used was a modification of the one previously
described [27].
Microorganism
Freshly sub cultured (24 hours) C. albicans were used
throughout this study. The C. albicans were grown in
Sabouraud Dextrose (SD) Agar and SD Broth (BD Difco™,
Franklin Lakes, New Jersey, USA).
Dentine block specimens
A total of 90 intact freshly extracted human teeth, in-
cluding maxillary central incisors, maxillary lateral inci-
sors, maxillary canines and mandibular canines with
complete root formation were selected for this study.
The teeth were cleaned with periodontal curettes to re-
move periodontal tissues and bone and stored in saline.
A low-speed diamond edge-coated disc (Bredent®,
Wittighausen, Senden, Germany) mounted on a milling ma-
chine under water cooling was used to section the teeth
below the cementoenamel junction and the apical part
of the root to obtain 6 mm of the middle third of the
root. Root cementum was removed using long cylin-
drical diamond burs, in a high-speed handpiece (Kavo®,
Charlotte, North Carolina, USA), under water cooling
to obtain a dentine block. Pesso Reamer no. 2 (Mani®,
Utsunoniya, Tochigi, Japan) in a low-speed handpiece
(Kavo, Charlotte, North Carolina, USA) was used to
standardize the internal diameter (0.9 mm) of root ca-
nals. The dentine blocks were subjected to ultrasonic
irrigation (EndoActivator, Dentsply, Weybridge, Surrey,
UK) using 5.25% sodium hypochlorite (Clorox®, Oakland,
California, USA) and then 17% EDTA (Calasept®, Nor-
diska Dental, Ängelholm, Skåne Country, Sweden) for
one minute to remove smear layer. The dentine blocks
were thoroughly rinsed with sterile saline after each ir-
rigation. Next, the dentine blocks were subjected to
sterilization by autoclave (LTE®, Oldham, Lancashire,
UK) for 20 minutes at 121°C.
The outer surfaces of the specimens were covered with
nail varnish to prevent contact of the C. albicans medic-
ament with the external surface. Ten petri dishes contain-
ing wax with a flat surface were prepared, and surface
sterilized using 70% ethanol and air dried in a sterile bio-
safety cabinet before use. The dentine blocks were up
righted, and the apical ends were fixed to the petri dishes
with wax, with a thin small square of sterilized plastic strip
obliterating the apical orifice to prevent any softened wax
from entering the canals.
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C. albicans were suspended in 20.0 ml of SD broth. The
cell suspension was adjusted to match the turbidity of
1.5 × 10 [8] CFU mL−1 (equivalent to 0.5 McFarland
standards). The fungal inoculum was transferred into
the dentine blocks with the use of sterile 5.0 mL syringes
(Terumo®, Somerset, New Jersey, USA) with 30-gauge
needles (Terumo, Somerset, New Jersey, USA) in a ster-
ile laminar flow hood. The coronal part of the dentine
blocks were then sealed immediately using Parafilm
(Parafilm M®, Brand, Wertheim, Baden-Württemberg,
Germany). The dentine blocks were incubated at 37°C
for 21 days, with renewal of C. albicans every 3 days.
Placement of intracanal medicaments
Following the inoculation period, the canal of dentine
blocks were irrigated with sterile saline and dried with
sterile paper points. The 90 dentine blocks were divided
into five groups, according to the intracanal medicament
used, as follows:
 Group I (20 specimens): 95% propolis (Stakich,
Royal Oak, Michigan, USA) was mixed with saline
in a ratio of 1.5:1 (wt/vol) to obtain a paste like
consistency.
 Group II (20 specimens): Mix of equal weight (1:1:1)
of ground metronidazole (UPL, Ankleshwar, Gujarat,
India), ciprofloxacin (Apex Pharmacy, Petaling Jaya,
Selangor, Malaysia) and minocycline (YSP, Kuala
Lumpur, Selangor, Malaysia) was mixed with sterile
saline in a ratio of 1.5:1 (wt/vol) to obtain a paste
like consistency.
 Group III (20 specimens): 2% chlorhexidine gel
(Consepsis V®, Ultradent, South Jordan, Utah, USA).
 Group IV (20 specimens): non-setting Ca(OH)2
(Produits Dentaires SA, Vevey, Vaud, Switzerland)
was mixed with propylene glycol in a ratio of 1.5:1
(wt/vol) to obtain a paste like consistency.
 Group V (10 specimens) sterile saline as matched
untreated control group to provide base line data on
fungal growth over time.
Each group was further divided into two subgroups:
subgroups I (A1 and A2), subgroups II (B1 and B2), sub-
groups III (C1 and C2), subgroups IV (D1 and D2), and
subgroups V (E1 and E2) according to the experimental
periods.
The intracanal medicaments were placed in the canal
with the help of sterile 5.0 mL syringes (Terumo®, Somerset,
New Jersey, USA) and gel etchant needle tip (Kerr®, Orange,
California, USA) until the canals were completely filled.
Following the placement of all intracanal medicaments
inside the dentinal blocks, the coronal orifices were all
sealed with Parafilm (Parafilm M®, Brand, Wertheim,Baden-Württemberg, Germany). The blocks were kept
at 37°C according to the experimental periods (1 and
7 days).
Collection of dentinal shavings
At the end of the experimental periods, the dentine blocks
were removed from the petri dishes and the canals were
irrigated using sterile saline and the canal walls were
cleaned using ultrasonic tips to ensure complete removal
of the medicament. The canals were dried with sterile
paper points. Samples of dentinal shavings were collected
after day 1 medicament for A1, B1, C1, D1 and E1, and
after day 7 for A2, B2, C2, D2 and E2.
Dentinal shavings were collected using Pesso Reamer
(Mani®, Utsunoniya, Tochigi, Japan) size no. 4 (1.3 mm
diameter) followed by size no. 6 (1.7 mm diameter), in a
low speed handpiece (Kavo®, Charlotte, North Carolina,
USA). These sizes of the pesso reamers allow a depth of
200 μm and 400 μm of dentinal shavings to be collected
(Figure 1). Dentinal shavings were transferred immedi-
ately into a micro-centrifuge tube (Axygen®, Corning,
Tweksburry, Massachusets, USA) containing 1.0 ml
sterile SD broth.
Antimicrobial assessment
A sterile micro tip was used to take 0.1 ml of broth con-
taining dentinal shavings, transferred to another tube
containing 0.9 ml sterile SD broth. The content of each
tube was serially diluted from 10−1 until 10−7. 300 μl of
the diluted shavings was spread evenly using a L-shaped
glass rod and triplicated on three occasions. These plates
were incubated for 24 hours at 37°C and the colonies
were counted and readings were tabulated.
Statistical analysis
The SPSS computer software version 18.0 (SPSS Inc.,
Chicago, Illinois, USA) was used to perform statistical
analysis. The values were analysed using non-paramatric
Kruskal-Wallis and Mann–Whitney-U tests to compare
the median reduction of Candida albicans between all
intracanal medicaments. Probability values of P < 0.05 were
set as the reference for statistically significant results.
Results
The control group showed viable C. albicans at all experi-
mental times, confirming the efficiency of the methodology.
Non-parametric Kruskal Wallis test showed significance
differences between the intracanal medicaments and
saline on both days and at different depths (Table 1).
Table 2 shows the median and percentage difference
difference in CFU between various intracanal medica-
ments. When the results were compared to the untreated
control group (sterile saline), the p-value shown could be
attributed directly to the effect of the medicaments tested.
Figure 1 Schematic presentation of the cross section of root canal dentine and drill size selection. Pesso Reamer (Mani®, UT, Japan) size
no. 4 (1.3 mm diameter) and no. 6 (1.7 mm) allowed a depth of 0.2 mm (200 μm) and 0.4 mm (400 μm) of dentinal shavings to be collected a
0.9 mm diameter canal respectively.
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On the day 1, all medicaments showed highly significant
fungal reduction (p < 0.005) when compared to the con-
trol (sterile saline). When the four medicaments were
compared to each other, CHX showed the best antifungal
activity (p < 0.005), followed by Ca(OH)2 with propylene
glycol which was better than propolis (p < 0.005) but no
difference to TAP (p > 0.05). TAP showed no significant
difference compared to propolis (p > 0.05) (Figure 2).
At day 7, all medicaments showed highly significant
fungal reduction (p < 0.005) when compared to the con-
trol (sterile saline). When the four medicaments were
compared to each other, CHX showed highly significant
difference only with propolis (p < 0.005) with no signifi-
cant difference to Ca(OH)2 with propylene glycol and
TAP. Ca(OH)2 with propylene glycol showed significant
difference with propolis (p < 0.05) with no significant
difference with TAP (p > 0.05). TAP also showed highly
significant difference to propolis (p < 0.005) (Figure 2).
Fungal reduction at 400μm dentinal tubule depth
At day 1, when compared to the control (sterile saline),
all medicaments showed highly significant fungal reduc-
tion (p < 0.005) except propolis (p > 0.05). When the four
medicaments were compared to each other, CHX wasTable 1 Comparison of CFUs between the tested medicament
N Day 1
200 μm 400 μm
Median Q3-Q1 Median
Saline 5 3.49×107 1.90×107 3.40×105
Propolis 10 4695.00 4.95×105 1.15×105
TAP 10 1502.25 3520.61 1052.63
CHX 10 4.25 172.83 3.25
Ca(OH)2-PG 10 865.00 2107.88 207.83
Median and Interquartile range of all the groups are also shown.the best with a highly significant difference compared to
other three medicaments (p < 0.005). Ca(OH)2 with propyl-
ene glycol showed significantly better results than to TAP
(p < 0.05) and highly significant to propolis (p < 0.005). TAP
was significantly better than propolis (p < 0.05) (Figure 3).
At day 7, when compared to the control (sterile sa-
line), all medicaments showed highly significant fungal
reduction (p < 0.005). When the four medicaments were
compared to each other, CHX showed highly significant
difference (p < 0.005) to TAP and propolis but no signifi-
cant difference to Ca(OH)2 with propylene glycol (p > 0.05).
Ca(OH)2 with propylene glycol and TAP showed highly
significant difference to propolis (p < 0.005) but no signifi-
cant difference among each other (p > 0.05) (Figure 3).
Discussion
The use of a biocompatible intracanal medicament with
antimicrobial properties between appointments may
completely eradicate the micro-organisms from the root
canal system and could significantly increase the success
of root canal treatment [28]. The in vitro model devel-
oped by Haapasalo & Orstavik has been used to assess
the efficacy of endodontic medicaments in the disinfec-
tion of dentinal tubules [27]. In the present study, this
model was modified to include natural human teeth ass and saline
Day 7
200 μm 400 μm
Q3-Q1 Median Q3-Q1 Median Q3-Q1
2.46×105 2.08×107 8.95×106 3.06×105 96500.00
5.33×105 896.00 53835.21 8426.67 15389.54
13013.58 28.75 24.13 59.25 153.21
76.67 21.75 101.13 1.00 25.00
461.91 29.25 423.42 6.25 107.75
Table 2 Mann–Whitney U-test to study the difference between various intracanal medicaments and CFU
Day 1 Day 7
200 μm 400 μm 200 μm 400 μm
Median reduction in
CFU(%)
p value Median reduction in
CFU(%)
p value Median reduction in
CFU(%)
p value Median reduction in
CFU(%)
p value
Saline vs Propolis 3.49x107 (99.98%) 0.003 2.25×105 (66.18%) 0.096 2.08×107 (99.99%) 0.003 2.98×105 (97.25%) 0.003
Saline vs TAP 3.49x107 (99.99%) 0.003 3.39×105 (99.69%) 0.013 2.08×107 (99.99%) 0.003 3.06×105 (99.98%) 0.003
Saline vs CHX 3.49x107 (99.99%) 0.003 3.40×107 (99.99%) 0.003 2.08×107 (99.99%) 0.003 3.06×105 (99.99%) 0.003
Saline vs Ca(OH)2-PG 3.49x10
7 (99.99%) 0.003 3.40×105 (99.99%) 0.003 2.08×107 (99.99%) 0.003 3.06×105 (99.99%) 0.003
Propolis vs TAP 3192.75 (68%) 0.102 1.14×105 (99.08%) 0.021 867.25 (96.79%) 0.001 8367.42 (99.30%) 0.001
Propolis vs CHX 4690.75 (99.91%) 0.001 1.15×105 (99.99%) 0.000 874.25 (97.57%) 0.003 8425.67 (99.99%) 0.000
Propolis vs Ca(OH)2-PG 3830.00 (81.58%) 0.047 1.15×10
5 (99.82%) 0.001 866.75 (96.74%) 0.012 8420.42 (99.93%) 0.001
TAP vs CHX 1498.00 (99.71%) 0.004 3347.78 (95.09%) 0.001 7.00 (24.34%) 0.965 58.25 (98.31%) 0.004
TAP vs Ca(OH)2-PG 637.25 (42.42%) 0.847 844.80 (80.24%) 0.027 0.50 (1.71%) 0.627 50.00 (84.39%) 0.102
CHX vs Ca(OH)2-PG 860.75 (99.51%) 0.002 204.58 (98.44%) 0.004 7.50 (25.64%) 0.354 5.25 (84.00%) 0.157
*p-value < 0.05 was considered as statistically significant.
***p-value < 0.005 was considered as highly significant.
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clinical settings. Sectioning and shaping of the canal
were maintained to a standard of 6.0 mm in height and
0.9 mm in diameter to ensure placing an uniform quan-
tity of fungi during inoculation, and intracanal medica-
ments. Also, quantitative analysis of fungi in the dentine
tubules was done to define a percentage of reduction in
CFU in infected dentine before and after the application
of intracanal medicaments. C. albicans was chosen due
to the presence of the organism in 7-18% cases of per-
sistent apical periodontitis [4].
In the present study, 2% chlorhexidine gel was effect-
ive for C. albicans at dentinal tubule depths of 200 μm
and 400 μm on day 1 and day 7 the fungicidal inhibitionFigure 2 Comparison of percentage reduction in median CFU intraca
day 7. (p value < 0.05 = *, p < 0.01 = **, p < 0.001 = ***).were found to be statistically significant. The possible
reason could be that, the bactericidal dosage of 2% and
gel formulation helps to retain the CHX in close prox-
imity to the root canal walls and dentinal tubules
[29,30]. The CHX innate substantive properties inhibits
re-infection for a duration of at least 12 weeks [31,32].
The result of the present study was similar to that of
Vaghela et al., who showed that CHX had the highest
fungicidal activity at 200 μm and 400 μm [12]. However,
CHX should be used cautiously when sodium hypo-
chlorite (NaOCl) was used as a root canal irrigant previ-
ously. This is because the reaction between NaOCl and
CHX leads to the formation of an orange-brown precipi-
tate, resulting in a chemical smear layer that covers thenal medicaments at 200 μm dentinal tubule depths on day 1 and
Figure 3 Comparison of percentage reduction in median CFU intracanal medicaments at 400 μm dentinal tubule depths on day 1 and
day 7. (p value < 0.05 = *, p < 0.01 = **, p < 0.001 = ***).
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root canal filling. In addition, this precipitate may be
cytotoxic to periapical tissues. The other limitation in-
cludes the cytotoxic effect with live tissues for extended
periods, as demonstrated in the literature [33]. There-
fore, thorough flushing of root canal is mandatory before
using CHX as an intracanal medicament.
The fungicidal effect of propolis was statistically sig-
nificant in eliminating C. albicans at dentinal tubule
depths of 200 μm on day 1 and at both depths on day 7.
However, the reduction was not statistically significant
at the depth of 400 μm on day 1. The possible reason
for lower antifungal activity of propolis on day 1, at the
depth of 400 μm could be due to the slower rate of
penetration in the dentinal tubules. The diffusing prop-
erty of the medicaments could be improved by adding
vehicles such as propylene glycol. The antifungal action
of propolis is due to the presences of flavonoids and
phenolic acids which interact with the cellular sulphy-
dryl compounds on the cell wall. This damages the in-
tegrity of the yeast cell wall and results in detachment of
fungal cell wall and reduction of germ tube formation
and hyphal length. As a result, it inhibits yeast-mycelial
conversion which ultimately prevents cell division [22,23].
In addition, the anti-inflammatory and anti-oxidant prop-
erties of propolis could further enhance the healing of the
periapical tissue. However, the application of propolis
should be avoided in patients who are known to be aller-
gic to pollen [34].
Calcium hydroxide with propylene glycol resulted in
statistically significant inhibition of C. albicans at den-
tinal tubule depths of 200 μm and 400 μm at day 1 and
day 7. Calcium hydroxide reacts by releasing hydroxylions leading to a highly alkaline environment which mi-
croorganisms cannot survive. Chemically it damages the
microbial cytoplasmic membrane, suppresses enzyme ac-
tivity and disrupts the cellular metabolism or microor-
ganisms [8]. Calcium hydroxide is the most widely used
intracanal medicaments, mainly in teeth with apical peri-
odontitis. It has several beneficial properties, such as
antimicrobial effect, tissue compatibility, ability to in-
duce the formation of mineralized tissue, inactivation of
bacterial endotoxin and ability to promote repair. How-
ever, C. albicans have been shown to be resistant to it
[7]. In the present study, calcium hydroxide was effective
which probably is due to the addition of a vehicle, namely
propylene glycol, which allows the release of hydroxyl ions
for a longer period, and enhances the diffusibility of cal-
cium hydroxide into the dentinal tubules [35]. The result
of the present study was similar to the study of Vaghela et
al., demonstrated that calcium hydroxide with propylene
glycol had high antifungal activity at 200 μm and 400 μm
[10]. However, calcium hydroxide in its high pH may
cause necrosis of the surrounding tissue, and long term
use may increase brittleness of root dentin which in-
creases the risk of future cervical root fractures [36].
Triple antibiotic paste delivered statistically significant
inhibition of C. albicans at dentinal tubule depths of
200 μm and 400 μm at day 1 and day 7. Triple antibiotic
paste contains minocycline which inhibits protein syn-
thesis on the surfaces of ribosome which might be the
reason for the antifungal property, while metronidazole
and ciprofloxacin can help fibroblasts to generate the
synthesis of extracellular matrix and collagen and contrib-
ute to the development of structural framework [16,37].
Triple antibiotic paste (TAP) was able to penetrate into
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organisms, anaerobic, gram-positive and gram negative
microorganisms [15]. TAP promotes healing, repairs peri-
apical tissue besides creating an aseptic environment and
accelerates functional development of the pulp-dentin
complex [38]. However, care should be taken in patients
who are known to be allergic to tetracycline, and also in
anterior teeth where discolouration could be caused by
minocycline [36].
Conclusions
Propolis was less effective than triple antibiotic paste, 2%
chlorhexidine gel and calcium hydroxide with propylene
glycol against C. albicans on day 1 at 400 μm deep in-
side the dentinal tubules, but equally effective after
7 days at both depths.
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